AMRI will close its Holywell, UK facility and cease operations by the end of 2015. The Holywell site provides chemical development services and small- and large scale-manufacturing services of APIs and intermediates. Activities at the Holywell site will be transitioned to other facilities within AMRI’s network, resulting in the loss of approximately 62 positions.   “This was a difficult decision as it impacts team members who have made valuable contributions to AMRI,” said William S....